Recent CRVO News
- CervoMed Announces Late-Breaking Presentations at Alzheimer’s Association® International Congress 2025 • GlobeNewswire Inc. • 07/08/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/25/2025 09:10:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/25/2025 09:05:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/25/2025 09:04:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/25/2025 09:03:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/25/2025 09:02:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/25/2025 09:01:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/25/2025 09:00:16 PM
- CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization • GlobeNewswire Inc. • 06/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2025 08:11:47 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/12/2025 09:13:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 08:29:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2025 01:06:44 PM
- CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 05/12/2025 12:00:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/07/2025 06:52:01 PM
- CervoMed to Participate in H.C. Wainwright 3rd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/07/2025 12:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2025 08:26:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/18/2025 04:32:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2025 08:06:35 PM
- Investigators to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD™ 2025 • GlobeNewswire Inc. • 04/02/2025 11:00:00 AM
- CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™) • GlobeNewswire Inc. • 03/25/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2025 08:06:53 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/17/2025 12:57:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/17/2025 12:19:21 PM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM